KCA
VERA icon

KVP Capital Advisors’s Vera Therapeutics VERA Stock Holding History

KVP Capital Advisors’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.4M Hold
32,700
– – 1.03% 32
2026
Q1 		$1.32M Hold
32,700
– – 0.98% 30
2025
Q4 		$1.66M Buy
+32,700
New +$1.16M 1.6% 20

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

KVP Capital Advisors's VERA Position: Q2 2026 in Review

KVP Capital Advisors held its Vera Therapeutics (VERA) position steady in Q2 2026 at 32,700 shares worth $1.4M. The position accounts for 1.03% of the portfolio, ranked #32.

KVP Capital Advisors first reported a position in VERA in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.66M in Q4 2025. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • KVP Capital Advisors held 32,700 shares of Vera Therapeutics worth $1.4M as of Q2 2026.
  • KVP Capital Advisors left its Vera Therapeutics share count unchanged in Q2 2026.
  • Vera Therapeutics made up 1.03% of KVP Capital Advisors's portfolio in Q2 2026, its #32 holding.
  • KVP Capital Advisors first reported a position in Vera Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • KVP Capital Advisors's Vera Therapeutics position peaked at $1.66M in Q4 2025.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on KVP Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.